TY - JOUR
T1 - Femtosecond Laser-Assisted Cataract Surgery Versus Phacoemulsification Cataract Surgery (FACT)
T2 - A Randomized Noninferiority Trial
AU - Day, Alexander C.
AU - Burr, Jennifer M.
AU - Bennett, Kate
AU - Bunce, Catey
AU - Doré, Caroline J.
AU - Rubin, Gary S.
AU - Nanavaty, Mayank A.
AU - Balaggan, Kamaljit S.
AU - Wilkins, Mark R.
AU - Aiello, Francesco
AU - Ali, Muna
AU - Allan, Bruce
AU - Boston, Hayley
AU - Chandler, Torsten
AU - Dhallu, Sandeep
AU - Elkarmouty, Ahmed
AU - Gambell, Joanna
AU - Hunter, Rachael
AU - Ikeji, Felicia
AU - Ilango, Balasubramaniam
AU - Jones, Emma
AU - Jones, Gemma
AU - Koshy, John
AU - Lau, Nicola
AU - Maurino, Vincenzo
AU - Muthusamy, Kirithika
AU - Round, Jeffrey
AU - Singh, Jasmin
AU - Sylvestre, Yvonne
AU - Wormald, Richard
AU - Yang, Yit
PY - 2020/8
Y1 - 2020/8
N2 - Purpose: To report the 3-month results of a randomized trial (Femtosecond Laser-Assisted Cataract Trial [FACT]) comparing femtosecond laser-assisted cataract surgery (FLACS) with standard phacoemulsification cataract surgery (PCS). Design: Multicenter, randomized controlled trial funded by the UK National Institute of Health Research (HTA 13/04/46/). Participants: Seven hundred eighty-five patients with age-related cataract. Methods: This trial took place in 3 hospitals in the UK National Health Service (NHS). Randomization (1:1) was stratified by site, surgeon, and 1 or both eyes eligible using a secure web-based system. Postoperative assessments were masked to the allocated intervention. The primary outcome was unaided distance visual acuity (UDVA) in the study eye at 3 months. Secondary outcomes included corrected distance visual acuity, complications, and patient-reported outcomes measures. The noninferiority margin was 0.1 logarithm of the minimum angle of resolution (logMAR). ISRCTN.com registry, number ISRCTN77602616. Main Outcome Measures: We enrolled 785 participants between May 2015 and September 2017 and randomly assigned 392 to FLACS and 393 to PCS. At 3 months postoperatively, mean UDVA difference between treatment arms was −0.01 logMAR (−0.05 to 0.03), and mean corrected distance visual acuity difference was −0.01 logMAR (95% confidence interval [CI], −0.05 to 0.02). Seventy-one percent of both FLACS and PCS cases were within ±0.5 diopters (D) of the refractive target, and 93% of FLACS and 92% of PCS cases were within ±1.0 D. There were 2 posterior capsule tears in the PCS arm and none in the FLACS arm. There were no significant differences between arms for any secondary outcome. Conclusions: Femtosecond laser-assisted cataract surgery is not inferior to conventional PCS surgery 3 months after surgery. Both methods are as good in terms of vision, patient-reported health, and safety outcomes at 3 months. Longer-term outcomes of the clinical effectiveness and cost-effectiveness are awaited.
AB - Purpose: To report the 3-month results of a randomized trial (Femtosecond Laser-Assisted Cataract Trial [FACT]) comparing femtosecond laser-assisted cataract surgery (FLACS) with standard phacoemulsification cataract surgery (PCS). Design: Multicenter, randomized controlled trial funded by the UK National Institute of Health Research (HTA 13/04/46/). Participants: Seven hundred eighty-five patients with age-related cataract. Methods: This trial took place in 3 hospitals in the UK National Health Service (NHS). Randomization (1:1) was stratified by site, surgeon, and 1 or both eyes eligible using a secure web-based system. Postoperative assessments were masked to the allocated intervention. The primary outcome was unaided distance visual acuity (UDVA) in the study eye at 3 months. Secondary outcomes included corrected distance visual acuity, complications, and patient-reported outcomes measures. The noninferiority margin was 0.1 logarithm of the minimum angle of resolution (logMAR). ISRCTN.com registry, number ISRCTN77602616. Main Outcome Measures: We enrolled 785 participants between May 2015 and September 2017 and randomly assigned 392 to FLACS and 393 to PCS. At 3 months postoperatively, mean UDVA difference between treatment arms was −0.01 logMAR (−0.05 to 0.03), and mean corrected distance visual acuity difference was −0.01 logMAR (95% confidence interval [CI], −0.05 to 0.02). Seventy-one percent of both FLACS and PCS cases were within ±0.5 diopters (D) of the refractive target, and 93% of FLACS and 92% of PCS cases were within ±1.0 D. There were 2 posterior capsule tears in the PCS arm and none in the FLACS arm. There were no significant differences between arms for any secondary outcome. Conclusions: Femtosecond laser-assisted cataract surgery is not inferior to conventional PCS surgery 3 months after surgery. Both methods are as good in terms of vision, patient-reported health, and safety outcomes at 3 months. Longer-term outcomes of the clinical effectiveness and cost-effectiveness are awaited.
UR - http://www.scopus.com/inward/record.url?scp=85088608361&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2020.02.028
DO - 10.1016/j.ophtha.2020.02.028
M3 - Article
C2 - 32386810
AN - SCOPUS:85088608361
SN - 0161-6420
VL - 127
SP - 1012
EP - 1019
JO - Ophthalmology
JF - Ophthalmology
IS - 8
ER -